Vivimed Labs confirms compliance with SEBI (Depositories and Participants) Regulations for Q2 FY26
Vivimed Labs confirmed compliance with SEBI (Depositories and Participants) Regulations 74(5) for the quarter ended 30th September, 2025, as certified by its RTA, Aarthi Consultants Private Limited.
This is a standard, expected compliance update required by SEBI regulations. It does not indicate any material changes to the company's operations, finances, or strategic direction, hence the low impact.
The announcement is a routine regulatory compliance filing, confirming standard procedures have been followed. It does not contain information that would typically lead to a positive or negative market reaction.
Vivimed Labs Limited has submitted a certificate from its Registrar and Share Transfer Agent (RTA), Aarthi Consultants Private Limited, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. * The compliance specifically covers the quarter ended 30th September, 2025. * Aarthi Consultants Private Limited confirmed that within 15 days of receiving security certificates from depository participants for dematerialization during the period from 1st July, 2025 to 30th September, 2025, they have: * Ensured the dematerialized securities are listed on the relevant stock exchanges. * Mutilated and cancelled the forwarded security certificates. * Substituted the name of the depository as the registered owner in their records.
What to do with a filing like this
Vivimed Labs Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vivimed Labs Limited. Read the original for the full detail.